Prostaglandin E2 (PGE2)
别名: Dinoprostone 中文名称：前列腺素E2
Prostaglandin E2 (PGE2, Dinoprostone) 在分娩中发挥重要作用（可软化宫颈，引起子宫收缩），也刺激成骨细胞释放能刺激破骨细胞吸收的因子。
Prostaglandin E2 (PGE2) Chemical Structure
CAS: 363-24-6
客户使用Selleck的发表文献17篇
产品质控
Prostaglandin E2 (PGE2)相关产品
| 相关化合物库 | FDA药物库 天然产物库 已知活性药物库-I 外泌体分泌相关化合物库 人类激素相关化合物库 | 点击展开 |
|---|
PGES抑制剂选择性比较
细胞实验数据示例
| 细胞系 | 实验类型 | 给药浓度 | 孵育时间 | 活性描述 | 文献信息 |
|---|---|---|---|---|---|
| CHO | Function assay | 100 nM | Activity at recombinant EP1 receptor (unknown origin) expressed in CHO cells co-expressing Gq protein at 100 nM by electrical cell substrate impedance sensing system | 25701254 | |
| CHO | Function assay | 100 nM | Activity at recombinant EP4 receptor (unknown origin) expressed in CHO cells co-expressing Gs protein at 100 nM by electrical cell substrate impedance sensing system | 25701254 | |
| CHO | Function assay | 100 nM | Activity at recombinant EP3 receptor (unknown origin) expressed in CHO cells co-expressing Gi protein at 100 nM by electrical cell substrate impedance sensing system | 25701254 | |
| CHO | Function assay | 60 mins | Displacement of [3H]-PGE2 from mouse EP4 receptor expressed in CHO cells after 60 mins by liquid scintillation counting, Ki = 0.0031 μM. | 22119471 | |
| CHO | Function assay | 60 mins | Displacement of [3H]-PGE2 from mouse EP3 receptor expressed in CHO cells after 60 mins by liquid scintillation counting, Ki = 0.005 μM. | 22119471 | |
| CHO | Function assay | 20 mins | Displacement of [3H]-PGE2 from mouse EP1 receptor expressed in CHO cells after 20 mins by liquid scintillation counting, Ki = 0.006 μM. | 22119471 | |
| CHO | Function assay | 60 mins | Displacement of [3H]-PGE2 from mouse EP2 receptor expressed in CHO cells after 60 mins by liquid scintillation counting, Ki = 0.022 μM. | 22119471 | |
| CHO | Function assay | 60 mins | Displacement of [3H]-PGE2 from mouse EP4 receptor expressed in CHO cells after 60 mins by scintillation counting, Ki = 0.0031 μM. | 22386979 | |
| CHO | Function assay | 60 mins | Displacement of [3H]-PGE2 from mouse EP3 receptor expressed in CHO cells after 60 mins by scintillation counting, Ki = 0.005 μM. | 22386979 | |
| CHO | Function assay | 60 mins | Displacement of [3H]-PGE2 from mouse EP1 receptor expressed in CHO cells after 60 mins by scintillation counting, Ki = 0.006 μM. | 22386979 | |
| CHO | Function assay | 60 mins | Displacement of [3H]-PGE2 from mouse EP2 receptor expressed in CHO cells after 60 mins by scintillation counting, Ki = 0.022 μM. | 22386979 | |
| CHEM1 | Function assay | 2 hrs | Displacement of [3H]PGE2 from human recombinant prostanoid EP4 receptor in CHEM1 cells after 2 hrs, Ki = 0.00045 μM. | 23403082 | |
| CHEM1 | Function assay | 2 hrs | Displacement of [3H]PGE2 from human recombinant prostanoid EP4 receptor in CHEM1 cells after 2 hrs, IC50 = 0.0011 μM. | 23403082 | |
| CHO | Function assay | 30 mins | Agonist activity at human EP2 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF method, EC50 = 0.0019 μM. | 26985320 | |
| CHO | Function assay | 30 mins | Agonist activity at human EP4 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF method, EC50 = 0.0075 μM. | 26985320 | |
| HEK293 | Function assay | 90 mins | Agonist activity at PK2-tagged human EP2 receptor expressed in HEK293 cells assessed as induction of EA-tagged beta-arrestin recruitment incubated for 90 mins by beta-galactosidase reporter gene assay, EC50 = 0.346 μM. | 26985320 | |
| CHO | Function assay | 30 mins | Agonist activity at human IP receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF method, EC50 = 0.347 μM. | 26985320 | |
| HEK293 | Function assay | 120 mins | Displacement of [3H]PGE2 from human recombinant EP4 receptor expressed in HEK293 cells measured after 120 mins by scintillation counting method, IC50 = 0.00055 μM. | 27876250 | |
| HEK293 | Function assay | 120 mins | Displacement of [3H]PGE2 from human recombinant EP2 receptor expressed in HEK293 cells measured after 120 mins by scintillation counting method, IC50 = 0.0026 μM. | 27876250 | |
| S2 | Function assay | TP_TRANSPORTER: uptake in OAT4-expressing S2 cells, Km = 0.154 μM. | 11907186 | ||
| S2 | Function assay | TP_TRANSPORTER: uptake in OCT2-expressing S2 cells, Km = 0.0289 μM. | 11907186 | ||
| HeLa | Function assay | TP_TRANSPORTER: uptake in PGT-expressing HeLa cells, K1/2 = 0.1 μM. | 8787677 | ||
| HeLa | Function assay | TP_TRANSPORTER: uptake in PGT-expressing HeLa cells, Km = 0.094 μM. | 7754369 | ||
| S2 | Function assay | TP_TRANSPORTER: uptake in OAT3-expressing S2 cells, Km = 0.345 μM. | 11907186 | ||
| S2 | Function assay | TP_TRANSPORTER: uptake in OCT1-expressing S2 cells, Km = 0.657 μM. | 11907186 | ||
| S2 | Function assay | TP_TRANSPORTER: uptake in OAT2-expressing S2 cells, Km = 0.713 μM. | 11907186 | ||
| S2 | Function assay | TP_TRANSPORTER: uptake in OAT1-expressing S2 cells, Km = 0.97 μM. | 11907186 | ||
| HEK293 | Function assay | Inhibitory activity against human EP4 receptor expressed in HEK293 ebna cells, IC50 = 0.0007 μM. | 12643927 | ||
| HEK293 | Function assay | EP4 agonist potency utilizing a stable clone of pSV40-EP4 transfected into HEK293 cells expressing EP4 receptor, EC50 = 0.003 μM. | 12643927 | ||
| Sf9 | Function assay | TP_TRANSPORTER: uptake (vesicle) in membrane vesicles from MRP4-expressing Sf9 cells, Km = 3.4 μM. | 12835412 | ||
| HEK293 | Function assay | Displacement of [3H]PGE2 from human EP3 receptor expressed in HEK293 cells, Ki = 0.00033 μM. | 17531488 | ||
| HEK293 | Function assay | Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells, Ki = 0.00079 μM. | 17531488 | ||
| HEK293 | Function assay | Displacement of [3H]PGE2 from human EP2 receptor expressed in HEK293 cells, Ki = 0.0049 μM. | 17531488 | ||
| HEK293 | Function assay | Displacement of [3H]PGE2 from human EP1 receptor expressed in HEK293 cells, Ki = 0.0091 μM. | 17531488 | ||
| HEK293 | Function assay | Agonist activity against rat EP2 receptor expressed in HEK293 cells assessed as stimulation of cAMP release, EC50 = 0.0002 μM. | 19250823 | ||
| HEK293 | Function assay | Agonist activity against rat EP4 receptor expressed in HEK293 cells assessed as stimulation of cAMP release, EC50 = 0.0007 μM. | 19250823 | ||
| HEK293 | Function assay | Inhibition of rat EP4 receptor expressed in HEK293 cells, IC50 = 0.0021 μM. | 19250823 | ||
| HEK293 | Function assay | Inhibition of rat EP2 receptor expressed in HEK293 cells, IC50 = 0.0052 μM. | 19250823 | ||
| CHO | Function assay | Agonist activity at human EP3 receptor expressed in CHO cells assessed as increase in intracellular calcium level by fluorescence based analysis, EC50 = 0.0025 μM. | 26985320 | ||
| CHO | Function assay | Agonist activity at human EP1 receptor expressed in CHO cells assessed as increase in intracellular calcium level by fluorescence based analysis, EC50 = 0.0037 μM. | 26985320 | ||
| Chem1 | Function assay | Agonist activity at human FP receptor expressed in human Chem1 cells assessed as increase in intracellular calcium level by fluorescence based analysis, EC50 = 0.25 μM. | 26985320 | ||
| HEK293 | Function assay | Displacement of [3H]PGE2 from human recombinant prostanoid EP2 receptor expressed in HEK293 cells, IC50 = 0.0026 μM. | 26988801 | ||
| 点击查看更多细胞系数据 | |||||
生物活性
| 产品描述 | Prostaglandin E2 (PGE2, Dinoprostone) 在分娩中发挥重要作用（可软化宫颈，引起子宫收缩），也刺激成骨细胞释放能刺激破骨细胞吸收的因子。 |
|---|
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT06129604 | Not yet recruiting | Colorectal Carcinoma (CRC)|Endometrial Carcinoma (EC) |
University of Oklahoma |
January 2024 | Phase 2 |
| NCT06190132 | Completed | Uremic Pruritus in Hemodialysis Patients |
Ain Shams University |
April 1 2023 | Not Applicable |
| NCT05412810 | Recruiting | Mechanical Ventilation Complication|Hyperoxia |
Ohio State University |
March 1 2023 | -- |
化学信息&溶解度
| 分子量 | 352.47 | 分子式 | C20H32O5 |
| CAS号 | 363-24-6 | SDF | Download Prostaglandin E2 (PGE2) SDF |
| Smiles | CCCCCC(C=CC1C(CC(=O)C1CC=CCCCC(=O)O)O)O | ||
| 储存条件(自收到货起) | |||
|
体外溶解度 |
DMSO : 70 mg/mL ( (198.59 mM)； DMSO吸湿会降低化合物溶解度，请使用新开封DMSO) Ethanol : 70 mg/mL Water : 2.5 mg/mL |
摩尔浓度计算器 |
|
体内溶解度 现配现用，请按从左到右的顺序依次添加，澄清后再加入下一溶剂 |
动物体内配方计算器 | ||||
实验计算
动物体内配方计算器（澄清溶液）
第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量）
第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系Selleck为您提供正确的澄清溶液配方）
计算结果：
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于μL DMSO溶液（母液浓度mg/mL，注：如该浓度超过该批次药物DMSO溶解度，请先联系Selleck）；
体内配方配制方法：取μL DMSO母液，加入μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入μL ddH2O，混匀澄清。
体内配方配制方法：取μL DMSO母液，加入μL Corn oil，混匀澄清。
注意：1. 首先保证母液是澄清的；
2.一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
技术支持
在订购、运输、储存和使用我们的产品的任何阶段，您遇到的任何问题，均可以通过拨打我们的热线电话400-668-6834，或者技术支持邮箱tech@selleck.cn，直接联系到我们。我们会在24小时内尽快联系您。
如果有其他问题，请给我们留言。
* 必填项
